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Abstract
Background: Obsessive-compulsive disorder (OCD) affects young adults and has great impact on
the social, emotional and work spheres.
Methods: We measured perceived quality of life (QOL) in OCD patients, in order to analyse
socio-demographic and clinical factors that may be associated with QOL perception. 64 OCD
outpatients were assessed with the Mini International Neuropsychiatric Interview for DSM-IV, the
Yale-Brown Obsessions and Compulsions scale (Y-BOCS), Hamilton's depression scale and the SF-
36 self-administered global QOL perception scale.
Results: We found a correlation among Hamilton's scale scores and all SF-36 subscales. The
severity of the obsessive-compulsive disorder was correlated with all SF-36 subscales and with the
highest scores in Hamilton's scale. The obsessions subscale was correlated to all SF-36 subscales,
while the compulsions subscale was correlated only to social functioning, emotional role, mental
health and vitality. Compulsions were not related to general health perception. There were
significant differences between OCD patients and the Spanish general population in all SF-36
subscales except those related to physical health and pain. Gender, age, age of onset of the
disorder, years of evolution and marital status of the patients did not significantly affect quality of
life perception. Being employed was related to better scores in the subscale of physical role.
Patients with medical comorbidity scored lower in the subscales of general health, social
functioning and mental health. Patients with comorbid psychiatric disorders had worse scores in
the subscales of pain, general health, social functioning and mental health.
Conclusion: Quality of life perception was different in OCD patients and the general population.
Quality of life perception was related to severity of the disorder, physical and psychiatric
comorbidity and employment status.
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Background
The prevalence of obsessive-compulsive disorder (OCD)
has been recently estimated at 2% in the general popula-
tion [1-3]. Traditionally OCD was believed to be a much
more uncommon disorder. It has been hypothesised that
patients were reluctant to disclose OCD symptoms in
medical consultations and deliberately hid them from the
clinicians [4]. This meant that only the most severe cases
got to be evaluated by a specialist. The high comorbidity
of OCD with other psychiatric disorders (mainly anxiety
and depression) has also contributed to the underdiagno-
sis of OCD.
OCD may not be an extremely prevalent disorder [5], but
it has high clinical relevance. Its importance lies in its
deep impact on the patient's life and daily activities. This
is particularly relevant in OCD because this disorder
mainly affects young adults, who have a potentially high
level of activity in all the spheres of life. The above men-
tioned high comorbidity of OCD with other psychiatric
disorders [6,7] also entails a significant worsening of qual-
ity of life, and has further consequences in the social and
work spheres of the patient's life.
Once OCD has been diagnosed, measuring the financial
costs associated with health service use would seem rela-
tively easy. However, it is difficult to measure other factors
that influence the financial impact of OCD such as
impairment of quality of life and the effect of the disorder
on the family, social and work environments. Since OCD
is a chronic disease of relatively early onset, many of its
repercussions cover the entire life span of the individual
[8]. Regarding socio-economic variables, OCD patients
have higher unemployment rates, lower average income,
worse academic achievements and higher dependence
from social security allowances and payments. According
to data from the British National Survey of Psychiatric
Morbidity, only 48% of OCD patients perceived a salary,
16% were unemployed and 36% were financially inactive
[9]. 3% of non-institutionalised OCD patients have never
had a job, suggesting an even earlier onset of the disorder.
Data from North America are quite similar to these results
[8]. Unfortunately there are few data from Spain.
One Spanish group [10] used the SF-36 scale and com-
pared quality of life scores of OCD patients, general pop-
ulation and other groups of individuals (depressed
patients, hemodialysis patients and kidney transplant
receptors).
The aim of this study is to evaluate quality of life percep-
tion with the SF-36 scale in a sample of OCD outpatients,
in relation to the severity of the disorder, obsessions and
compulsions scales, socio-demographic data, comorbid-
ity and age of onset of the disorder. We hypothesise that:
1) OCD patients have worse quality of life perception
than the general population; 2) this is related to the sever-
ity of the clinical manifestations of the disorder; 3) the
most affected areas are social functioning, emotional role
and mental health.
Methods
Between November 2002 and November 2004, we
recruited 64 adult patients (older than 18) with OCD
diagnosis (according to DSM-IV criteria) at the psychiatric
outpatient clinic at Ramon y Cajal General Hospital. All
patients were receiving psychopharmacological treatment
and/or psychotherapy at the time of the study. All of them
agreed to participate in the study and signed a consent
form. The research carried out is in compliance with the
Helsinki Declaration. The name of the body which gave
approval is the Ethical Committee for Clinical Research
(Comité Ético de Investigación Clínica) of Ramon y Cajal
Hospital (record of meeting number 118, Research Project
042/03).
All patients were interviewed by a clinical psychiatrist and
assessed with the 5.0.0 Spanish version of the Mini Inter-
national Psychiatric Interview (MINI), the Hamilton scale
for depression (HRSD), and the self-administered SF-36
global quality of life perception scale. The SF-36 scale was
developed from the questionnaires used in the Medical
Outcomes Study [11-13]. The Spanish version of the SF-
36 was developed by Alonso et al [14] and validated by
Ayuso-Mateos et al [15]. The psychometric values of the
Spanish version of the SF-36 scale were similar to those of
the original scale. The SF-36 is a self-administered ques-
tionnaire that includes 36 items in 11 multi-answer
groups. It explores 8 dimensions (subscales) of health
state: physical functioning, social functioning, role limita-
tions (physical and emotional problems), mental health,
vitality, pain and general health perception. One addi-
tional question explores changes in the health state during
the previous year. All items and dimensions provide
scores (0–100) that are directly proportional to the health
state. The SF-36 detects both positive and negative health
states. The normalised reference scores for the Spanish
general population are shown in table 3[16].
OCD severity was evaluated with Yale-Brown's Obses-
sions and Compulsions Scale (Y-BOCS). Socio-demo-
graphic data were recorded for all patients, including
personal and family history of psychiatric disorders, evo-
lution of the current episode of the disorder and age of
onset (see table 1).
The statistical analysis was performed with the computer
program SPSS 11.5. We used 2-tailed Student's t-tests (for
dichotomous variables) and Analysis of Variance
(ANOVA, for variables with more than 2 categories) toBMC Psychiatry 2006, 6:20 http://www.biomedcentral.com/1471-244X/6/20
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compare SF-36 subscales scores among the categories of
categorical sociodemographic variables. We used Pear-
son's correlation to evaluate the correlations among the
SF-36 subscales scores and the test scores (global Y-BOCS,
compulsions subscale, obsessions subscale and Hamil-
ton's Depression Scale).
Results
Sample description
The clinical characteristics of the sample are described in
table 1.
Measures
The mean Y-BOCS (global, compulsions and obsessions
subscales) and Hamilton's scale scores are shown in table
2.
The comparison of SF-36 subscales scores in OCD
patients and the general population is shown in table 3.
There were significant differences in all SF-36 subscales,
except in those related to physical health and pain.
There were not significant differences in SF-36 subscales
scores among the categories of the demographic variables
Table 1: Sample description
Variables Mean (years) CI (95%) (years)
Age 36.4 33.6–37.2
Age of onset 20.7 18.5–22.9
%N
Gender Male 45.3 29
Female 54.7 35
Marital status Single 57.8 37
Married/living with a partner for 
longer than 6 months
40.6 26
Divorced 1.6 1
Education Primary 21.9 14
Secondary (Technical) 17.2 11
Secondary (Academic) 9.4 6
University preparatory course 4.7 3
University 46.9 30
Profession Housewife 12.7 8
Student 11.1 7
Blue collar 55.6 35
Civil servant 7.9 5
White collar 11.1 7
Working status Unemployed 40.6 26
Employed 59.4 38
History of medical disease Yes 40.6 26
No 59.4 38
Acute Medical Disease Yes 73.4 17
No 26.6 47
Chronic Medical Disease Yes 39.0 25
No 61.0 39
Psychiatric comorbidity Yes 46.9 30
No 53.1 34
Major depression 18.8 12
Disthymia 4.7 3
Substance abuse 14.1 9
Anxiety disorders 9.4 6
Other 10.9 7
More than one comorbid 
psychiatric disorder
14.1 9
History of psychiatric disorder Yes 48.4 31
No 51.6 33
Substance abuse Cannabis 6.2 4
Alcohol 3.1 2
Multiple 3.1 2
Clinical course Insidious onset, long evolution 73.0 46
Intermittent 17.5 11
malignant 9.5 6BMC Psychiatry 2006, 6:20 http://www.biomedcentral.com/1471-244X/6/20
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gender and marital status. Age, age of onset of the disorder
and years of evolution were not correlated to SF36 sub-
scales scores. However, patients who were employed
scored higher in the physical role subscale (t = -2.3; df =
62; p = 0.025). Patients with medical comorbidity had
worse health perception in the subscales of general health
(t = 2.1; df = 62; p = 0.037) and social functioning (t = 2.1;
df = 59.4; p = 0.038). Patients with psychiatric comorbid-
ity reported worse quality of life perception in the sub-
scales of pain (t = 2.6; df = 62; p = 0.011), general health
(t = 3.6; df = 58.4; p = 0.001), vitality (t = 2.8; df = 57.8; p
= 0.007), social functioning (t = 2.6; df = 62; p = 0.012)
and mental health (t = 3.2; df = 62; p = 0.002).
Y-BOCS global scores and Hamilton scale scores corre-
lated negatively to all SF-36 subscales scores. The Y-BOCS
obsessions subscale was negatively correlated to all SF-36
subscales. The Y-BOCS compulsions subscale was only
negatively correlated to the social functioning, emotional
role, mental health and vitality subscales of SF-36 (table
4). The SF-36 subscales that showed the weakest correla-
tion to the Y-BOCS obsessions subscale (those related to
physical functioning: physical function, physical role and
pain) showed no correlation at all to the compulsions
subscale. The compulsions subscale was not correlated to
general health perception.
We performed multiple regression analyses for all SF-36
subscales, using the SF-36 subscales scores as dependent
variable and the YBOCS scores (total, compulsions and
obsessions subscales) and Hamilton's scale scores as inde-
pendent variables. We found that Hamilton's scale scores
were negatively correlated to the SF-36 subscales related to
physical functioning (physical functioning and pain), and
to mental health, vitality and general health perception.
YBOCS scores were only correlated to vitality and general
health perception.
Discussion
Previous studies [17] have shown that patients with anxi-
ety and depressive disorders have higher levels of physical,
social and emotional impairment than other medical or
psychiatric patients.
The results of the present study are consistent with previ-
ous findings showing that OCD patients have signifi-
cantly decreased mean QOL scores for every SF-36
subscale except those related to physical health and pain
in comparison to the general population. However, in a
recent study Moritz et al [18] observed that OCD also
affected SF-36 subscales related to physical wellbeing.
We found a correlation among Hamilton scale scores and
all SF-36 subscales. This is consistent with the results of
other studies [18]. However, bad QOL perception in our
sample may not be attributable to depressive symptoms,
since the average Hamilton scale score was approximately
10 points. OCD had a clear negative repercussion on per-
ceived QOL, independently of affective symptoms.
Table 2: Mean Y-BOCS subscales and Hamilton's scale scores in OCD patients
Mean score SD Range
Y-BOCS (Global) 22.6 6.2 2–36
Y-BOCS (Obsessions) 11.3 3.0 0–18
Y-BOCS (Compulsions) 12.3 4.3 0–23
Hamilton's Depression Scale 9.4 5.6 1–25
Table 3: Comparison of SF-36 scores in the general Spanish population and OCD patients
SF-36 Subscales Scores in OCD 
patients (n = 
64)
Standard 
Deviation
Scores in the 
Spanish general 
population (n = 
9151)
Standard 
Deviation
tC I  9 5 % p  <
Physical 
functioning
80.1 22.7 84.7 24.0 -1.5 (-10.5, 1.3) 0.124
Physical role 54.3 41.4 83.2 35.2 -6.5 (-37.6, -20.2) 0.001
Pain 75.6 26.2 79.0 27.9 -0.9 (-10.2, 3.5) 0.331
Global health 51.0 22.2 68.3 22.3 -6.2 (-22.8, -11.8) 0.001
Vitality 40.6 19.6 66.9 22.1 -9.5 (-31.7, -20.9) 0.001
Social 
functioning
48.0 32.6 90.1 20.0 -16.7 (-47.1, -37.2) 0.001
Emotional role 35.4 44.4 88.6 30.1 -14.0 (-60.6, -45.8) 0.001
Mental health 45.7 19.9 73.3 20.1 -10.9 (-32.6, -22.7) 0.001BMC Psychiatry 2006, 6:20 http://www.biomedcentral.com/1471-244X/6/20
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Sociodemographic factors, age of onset, and years of evo-
lution of the disorder did not significantly affect QOL per-
ception. This is consistent with the results of some studies
[19]. However, other studies suggest that the delay in
OCD diagnosis [20] and the length of illness [18] worsen
QOL perception.
Other studies corroborate the impact of OCD on aca-
demic and work performance, social functioning and
QOL [18,20-22]. We found that being employed was
related to better scores in the SF-36 subscale of physical
role. This stresses the importance of employment status
on QOL in OCD patients.
We only found one study that assessed QOL perception in
Spanish OCD patients [10], and concluded that QOL per-
ception was worse in OCD patients than in the general
population. The most affected SF-36 subscales were social
functioning, emotional role and mental health. Their
results agree with ours and with other recent studies [18]
in that not all SF-36 subscales were equally affected.
We found that patients with medical comorbidity scored
lower in the subscales of general health and social func-
tioning. Other researchers have reported similar findings
in OCD populations without medical comorbidity
[10,22]. In our sample, patients with psychiatric comor-
bidity had worse scores in the subscales of pain, general
health, vitality, social functioning and mental health.
Koran et al [22] only found differences in mental health
perception. The discordance in the results may be related
to the low psychiatric comorbidity in Koran's sample
(20%) and to the fact that all patients in our sample (but
not in Koran's) [22] were receiving treatment at the time
of the study. Psychiatric comorbidity may be a confound-
ing factor since it may influence QOL perception. Previ-
ous studies have reported a negative effect of psychiatric
disorders on QOL perception [23-26].
The severity of OCD was correlated with all SF-36 sub-
scales and with the highest scores in Hamilton's scale. The
obsessions subscale was correlated to all SF-36 subscales,
while the compulsions subscale was correlated only to
social functioning, emotional role, mental health and
vitality. Compulsions were not related to general health
perception. Other authors have pointed out the positive
correlation between social impact and severity of the clin-
ical manifestations of the disorder [22]. It is noteworthy
that the scores in the compulsions subscale in our sample
were not negatively correlated with all SF-36 subscales.
Masellis et al [27] obtained similar results. This might be
related to the fact that compulsions are strategies to reduce
the anxiety generated by the obsessions [28]. Obsessions
are perceived as intrusive and uncontrollable, generate
marked uneasiness and have a greater impact on QOL
than compulsions, which may be considered necessary for
controlling the anxiety and discomfort. Evidence-based
psychological therapies for OCD pay more attention to
decreasing the compulsions than the obsessions [29], and
may be less useful for patients with predominantly obses-
sive manifestations. Between 17% and 44% of OCD
patients only experience obsessions [30]. This suggests
that treatments specifically aimed at reducing the anxiety
related to the obsessions may improve global QOL per-
ception in OCD patients, particularly in those with pre-
dominant obsessive symptoms. Cognitive therapy [30-33]
has been shown to be effective in patients with only
obsessive symptoms, though no studies have reported an
improvement in perceived QOL.
There are some limitations in our study. First, the sample
size makes it difficult to control for gender and comorbid-
ity. Second, the study design is transversal, meaning that
perceived QOL may be determined by multiple punctual
factors. This is magnified by the lack of control group.
Third, the use of general scales (instead of specific scales
for psychiatric patients) to measure perceived QOL may
bias the results.
Table 4: Correlation among Y-BOCS, Hamilton's depression scale and SF-36 subscales scores (only statistically significant results are 
shown)
SF-36 Y-BOC (Global)* Y-BOCS (Obsessions)* Y-BOCS 
(Compulsions)*
Hamilton's depression 
scale*
Physical functioning -0,3 p = 0,026 -0,3 p = 0,006 -0,5 p < 0,001
Social functioning -0,4 p < 0,001 -0,4 p = 0,001 -0,3 p = 0,005 -0,4 p = 0,005
Physical role -0,3 P = 0,014 -0,3 p = 0,024 -0,3 p = 0,014
Emotional role -0,4 P = 0,004 -0,3 p = 0,031 -0,4 p = 0,002 -0,3 p = 0,029
Mental health -0,4 p = 0.,001 -0,4 p = 0,003 -0,4 p = 0,002 -0,5 p < 0,001
Vitality -0,3 p = 0,027 -0,4 p = 0,004 -0,3 p = 0,009 -0,5 p < 0,001
Pain -0,3 p = 0,014 -0,3 p = 0,026 -0,4 p = 0,001
General health -0,5 p < 0,001 -0,5 p < 0,001 -0,6 p < 0,001
* Pearson's correlation, two-tailedBMC Psychiatry 2006, 6:20 http://www.biomedcentral.com/1471-244X/6/20
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Further research is needed on perceived QOL in OCD
patients, with bigger samples and control groups. Another
line of investigation should be to determine the degree to
which psychotherapies and pharmacological treatments
make emphasis on health perception and how these treat-
ments can improve the adaptation of OCD patients in
family, social and work environments.
Conclusion
In this sample, OCD had a clear negative repercussion on
perceived QOL except in the SF-36 subscales related to
physical health and pain. This suggests that not all areas
of the scale were altered by the disorder.
There was a correlation among Hamilton scale scores and
all SF-36 items. The severity of OCD was correlated with
all SF-36 areas and with the highest scores in Hamilton's
scale. The obsessions subscale was correlated to all SF-36
items, while the compulsions subscale was correlated only
to social functioning, emotional role, mental health and
vitality. This suggests that treatments aimed at reducing
the anxiety related to obsessions may improve global
QOL perception in OCD patients, particularly in those
with predominant obsessive symptoms.
Sociodemographic characteristics, age of onset and years
of evolution of OCD did not affect QOL perception. How-
ever, being employed was related to better scores in the
area of physical role.
Patients with medical comorbidity scored lower in general
health and social functioning. Patients with psychiatric
comorbididity had worse scores in the areas of pain, gen-
eral health, social functioning and mental health.
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